Loading clinical trials...
Loading clinical trials...
A Retrospective, Observational, Post-Marketing Study to Assess the Efficacy and Safety of Intravenous Infusions Polymyxin B and Colistin Methanesulfonate in Patients With Carbapenem-Resistant Gram-Negative Bacterial Infection
Conditions
Locations
1
Taiwan
Tri-Service General Hospital
Taipei, Taiwan
Start Date
November 26, 2025
Primary Completion Date
November 30, 2028
Completion Date
November 30, 2028
Last Updated
March 9, 2026
NCT06804096
NCT06135350
NCT07004049
NCT06162286
NCT07386912
NCT05531149
Lead Sponsor
TTY Biopharm
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions